Regulation of nuclear TDP-43 by NR2A-containing NMDA receptors and PTEN

Journal of Cell Science

Volumn 125, Issue 6, 2012, Pages 1556-1567

  Zheng, Mei ^a,b   Liao, Mingxia ^b   Cui, Tianyuan ^b   Tian, Honglin ^b   Fan, Dong Sheng ^a   Wan, Qi ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Glutamate neurotoxicity; Neurodegeneration; Neuroprotection; NR2A containing NMDA receptor; PTEN; TAR DNA binding protein 43

Indexed keywords

GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TAR DNA BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DNA-BINDING PROTEINS; FEMALE; MICE; MICE, INBRED C57BL; MOTOR NEURONS; NUCLEAR PROTEINS; PREGNANCY; PTEN PHOSPHOHYDROLASE; RECEPTORS, N-METHYL-D-ASPARTATE; TDP-43 PROTEINOPATHIES;

EID: 84861208499     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.095729     Document Type: Article

References (61)

1. Alilain, W. J. and Goshgarian, H. G. (2008). Glutamate receptor plasticity and activity-regulated cytoskeletal associated protein regulation in the phrenic motor nucleus may mediate spontaneous recovery of the hemidiaphragm following chronic cervical spinal cord injury. Exp. Neurol. 212, 348-357.
2. Annis, C. M. and Vaughn, J. E. (1998). Differential vulnerability of autonomic and somatic motor neurons to N-methyl-D-aspartate-induced excitotoxicity. Neuroscience 83, 239-249.
3. Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y. et al. (2006). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602-611.
4. Arai, T., Mackenzie, I. R., Hasegawa, M., Nonoka, T., Niizato, K., Tsuchiya, K., Iritani, S., Onaya, M. and Akiyama, H. (2009). Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol. 117, 125-136.
5. Arundine, M. and Tymianski, M. (2004). Molecular mechanisms of glutamatedependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 61, 657-668.
6. Ayala, Y. M., Zago, P., D'Ambrogio, A., Xu, Y. F., Petrucelli, L., Buratti, E. and Baralle, F. E. (2008). Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 121, 3778-3785.
7. Barmada, S. J., Skibinski, G., Korb, E., Rao, E. J., Wu, J. Y. and Finkbeiner, S. (2010). Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J. Neurosci. 30, 639-649.
8. Brunet, N., Tarabal, O., Esquerda, J. E. and Calderó, J. (2009). Excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord. J. Comp. Neurol. 516, 277-290.
9. Cairns, N. J., Neumann, M., Bigio, E. H., Holm, I. E., Troost, D., Hatanpaa, K. J., Foong, C., White, C. L., 3rd, Schneider, J. A., Kretzschmar, H. A. et al. (2007). TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am. J. Pathol. 171, 227-240.
10. Chang, N., El-Hayek, Y. H., Gomez, E. and Wan, Q. (2007). Phosphatase PTEN in neuronal injury and brain disorders. Trends Neurosci. 30, 581-586.
11. Chen, M., Lu, T. J., Chen, X. J., Zhou, Y., Chen, Q., Feng, X. Y., Xu, L., Duan, W. H. and Xiong, Z. Q. (2008). Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke 39, 3042-3048.
12. Corse, A. M., Bilak, M. M., Bilak, S. R., Lehar, M., Rothstein, J. D. and Kuncl, R. W. (1999). Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration. Neurobiol. Dis. 6, 335-346.
13. Culcasi, M., Lafon-Cazal, M., Pietri, S. and Bockaert, J. (1994). Glutamate receptors induce a burst of superoxide via activation of nitric oxide synthase in argininedepleted neurons. J. Biol. Chem. 269, 12589-12593.
14. DeRidder, M. N., Simon, M. J., Siman, R., Auberson, Y. P., Raghupathi, R. and Meaney, D. F. (2006). Traumatic mechanical injury to the hippocampus in vitro causes regional caspase-3 and calpain activation that is influenced by NMDA receptor subunit composition. Neurobiol. Dis. 22, 165-176.
15. Dingledine, R., Borges, K., Bowie, D. and Traynelis, S. F. (1999). The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61.
16. Fiesel, F. C., Voigt, A., Weber, S. S., Van den Haute, C., Waldenmaier, A., Görner, K., Walter, M., Anderson, M. L., Kern, J. V., Rasse, T. M. et al. (2010). Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J. 29, 209-221.
17. Fiszman, M. L., Ricart, K. C., Latini, A., Rodrĺguez, G. and Sica, R. E. (2010). In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses. Acta Neurol. Scand. 121, 120-126.
18. Gil, A., Andrés-Pons, A., Fernández, E., Valiente, M., Torres, J., Cervera, J. and Pulido, R. (2006). Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol. Biol. Cell 17, 4002-4013.
19. Gredal, O., Werdelin, L., Bak, S., Christensen, P. B., Boysen, G., Kristensen, M. O., Jespersen, J. H., Regeur, L., Hinge, H. H. and Jensen, T. S. (1997). A clinical trial of dextromethorphan in amyotrophic lateral sclerosis. Acta Neurol. Scand. 96, 8-13.
20. Grosskreutz, J., Van Den Bosch, L. and Keller, B. U. (2010). Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47, 165-174.
21. Hanson, K. A., Kim, S. H., Wassarman, D. A. and Tibbetts, R. S. (2010). Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS). J. Biol. Chem. 285, 11068-11072.
22. Hardingham, G. E., Fukunaga, Y. and Bading, H. (2002). Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405-414.
23. Hasegawa, M., Arai, T., Akiyama, H., Nonaka, T., Mori, H., Hashimoto, T., Yamazaki, M. and Oyanagi, K. (2007). TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 130, 1386-1394.
24. Igaz, L. M., Kwong, L. K., Xu, Y., Truax, A. C., Uryu, K., Neumann, M., Clark, C. M., Elman, L. B., Miller, B. L., Grossman, M. et al. (2008). Enrichment of Cterminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 173, 182-194.
25. Iguchi, Y., Katsuno, M., Niwa, J., Yamada, S., Sone, J., Waza, M., Adachi, H., Tanaka, F., Nagata, K., Arimura, N. et al. (2009). TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases. J. Biol. Chem. 284, 22059-22066.
26. Kidd, F. L. and Isaac, J. T. (2000). Glutamate transport blockade has a differential effect on AMPA and NMDA receptor-mediated synaptic transmission in the developing barrel cortex. Neuropharmacology 39, 725-732.
27. Kraemer, B. C., Schuck, T., Wheeler, J. M., Robinson, L. C., Trojanowski, J. Q., Lee, V. M. and Schellenberg, G. D. (2010). Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 119, 409-419.
28. Lafon-Cazal, M., Pietri, S., Culcasi, M. and Bockaert, J. (1993). NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
29. Lee, J. M., Zipfel, G. J. and Choi, D. W. (1999). The changing landscape of ischaemic brain injury mechanisms. Nature 399 Suppl. A7-A14.
30. Liu, B., Liao, M., Mielke, J. G., Ning, K., Chen, Y., Li, L., El-Hayek, Y. H., Gomez, E., Zukin, R. S., Fehlings, M. G. et al. (2006). Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J. Neurosci. 26, 5309-5319.
31. Liu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M. et al. (2007). NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857.
32. Mackenzie, I. R., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H. et al. (2007). Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann. Neurol. 61, 427-434.
33. Matyja, E., Taraszewska, A., Nagańska, E., Rafałowska, J. and Gebarowska, J. (2006). Astroglial alterations in amyotrophic lateral sclerosis (ALS) model of slow glutamate excitotoxicity in vitro. Folia Neuropathol. 44, 183-190.
34. Myers, M. P., Pass, I., Batty, I. H., Van der Kaay, J., Stolarov, J. P., Hemmings, B. A., Wigler, M. H., Downes, C. P. and Tonks, N. K. (1998). The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. USA 95, 13513-13518.
35. Nagańska, E., Taraszewska, A., Matyja, E., Grieb, P. and Rafałowska, J. (2010). Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study. Folia Neuropathol. 48, 35-44.
36. Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M. et al. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133.
37. Ning, K., Pei, L., Liao, M., Liu, B., Zhang, Y., Jiang, W., Mielke, J. G., Li, L., Chen, Y., El-Hayek, Y. H. et al. (2004). Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J. Neurosci. 24, 4052-4060.
38. Perry, T. L., Hansen, S. and Jones, K. (1987). Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 37, 1845-1848.
39. Plaitakis, A. and Caroscio, J. T. (1987). Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 22, 575-579.
40. Planchon, S. M., Waite, K. A. and Eng, C. (2008). The nuclear affairs of PTEN. J. Cell Sci. 121, 249-253.
41. Rothstein, J. D., Tsai, G., Kuncl, R. W., Clawson, L., Cornblath, D. R., Drachman, D. B., Pestronk, A., Stauch, B. L. and Coyle, J. T. (1990). Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28, 18-25.
42. Sarraf-Yazdi, S., Sheng, H., Miura, Y., McFarlane, C., Dexter, F., Pearlstein, R. and Warner, D. S. (1998). Relative neuroprotective effects of dizocilpine and isoflurane during focal cerebral ischemia in the rat. Anesth. Analg. 87, 72-78.
43. Schmid, A. C., Byrne, R. D., Vilar, R. andWoscholski, R. (2004). Bisperoxovanadium compounds are potent PTEN inhibitors. FEBS Lett. 566, 35-38.
44. Sen, I., Nalini, A., Joshi, N. B. and Joshi, P. G. (2005). Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor. J. Neurol. Sci. 235, 45-54.
45. Sephton, C. F., Good, S. K., Atkin, S., Dewey, C. M., Mayer, P., 3rd, Herz, J. and Yu, G. (2010). TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem. 285, 6826-6834.
46. Shan, Y., Liu, B., Li, L., Chang, N., Li, L., Wang, H., Wang, D., Feng, H., Cheung, C., Liao, M. et al. (2009). Regulation of PINK1 by NR2B-containing NMDA receptors in ischemic neuronal injury. J. Neurochem. 111, 1149-1160.
47. Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E. et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672.
48. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R. and Yamada, K. M. (1998). Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614-1617.
49. Terasaki, Y., Sasaki, T., Yagita, Y., Okazaki, S., Sugiyama, Y., Oyama, N., Omura-Matsuoka, E., Sakoda, S. and Kitagawa, K. (2010). Activation of NR2A receptors induces ischemic tolerance through CREB signaling. J. Cereb. Blood Flow Metab. 30, 1441-1449.
50. Tolosa, L., Mir, M., Asensio, V. J., Olmos, G. and Lladó, J. (2008). Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. J. Neurochem. 105, 1080-1090.
51. Traynor, B. J., Bruijn, L., Conwit, R., Beal, F., O'Neill, G., Fagan, S. C. and Cudkowicz, M. E. (2006). Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology 67, 20-27.
52. Turgeon, D., Carrier, J. S., Lévesque, E., Hum, D. W. and Bélanger, A. (2001). Relative enzymatic activity, protein stability, and tissue distribution of human steroidmetabolizing UGT2B subfamily members. Endocrinology 142, 778-787.
53. Van Westerlaak, M. G., Joosten, E. A., Gribnau, A. A., Cools, A. R. and Bär, P. R. (2001). Chronicmitochondrial inhibition induces glutamate-mediated corticomotoneuron death in an organotypic culture model. Exp. Neurol. 167, 393-400.
54. Vanhoutte, P. and Bading, H. (2003). Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation. Curr. Opin. Neurobiol. 13, 366-371.
55. Wan, Q., Man, H. Y., Braunton, J., Wang, W., Salter, M. W., Becker, L. and Wang, Y. T. (1997a). Modulation of GABAA receptor function by tyrosine phosphorylation of beta subunits. J. Neurosci. 17, 5062-5069.
56. Wan, Q., Xiong, Z. G., Man, H. Y., Ackerley, C. A., Braunton, J., Lu, W. Y., Becker, L. E., MacDonald, J. F. and Wang, Y. T. (1997b). Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature 388, 686-690.
57. Wang, J. Q., Tang, Q., Parelkar, N. K., Liu, Z., Samdani, S., Choe, E. S., Yang, L. and Mao, L. (2004). Glutamate signaling to Ras-MAPK in striatal neurons: mechanisms for inducible gene expression and plasticity. Mol. Neurobiol. 29, 1-14.
58. Weng, L. P., Brown, J. L. and Eng, C. (2001). PTEN coordinates G(1) arrest by downregulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum. Mol. Genet. 10, 599-604.
59. Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., Smits, V., Ceuterick-de Groote, C., Van Broeckhoven, C. and Kumar-Singh, S. (2010). TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA 107, 3858-3863.
60. Winton, M. J., Igaz, L. M., Wong, M. M., Kwong, L. K., Trojanowski, J. Q. and Lee, V. M. (2008). Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302-13309.
61. Wu, L. S., Cheng, W. C., Hou, S. C., Yan, Y. T., Jiang, S. T. and Shen, C. K. (2010). TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis 48, 56-62.